Literature DB >> 1173765

Therapy of depression by phenylalanine. Preliminary note.

E Fischer, B Heller, M Nachon, H Spatz.   

Abstract

To 23 subjects with endogenous depression after a previous unsuccessful treatment with common antidepressive drugs (imipramine-like or MAO inhibitors) dl- or d-phenylalanine was given in dialy oral doses of 50 or 100 mg during 15 days. A complete euthymia was obtained in 17 subjects between one and 13 days of treatment. No important adverse reaction was observed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1173765

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  6 in total

Review 1.  Amine precursor amino acid therapy: from neurochemical basis to clinical aspects.

Authors:  T Nakajima
Journal:  Neurochem Res       Date:  1996-02       Impact factor: 3.996

2.  Lithium prevention of amphetamine-induced 'manic' excitement and of reserpine-induced 'depression' in mice: possible role of 2-phenylethylamine.

Authors:  R L Borison; H C Sabelli; P J Maple; H S Havdala; B I Diamond
Journal:  Psychopharmacology (Berl)       Date:  1978-12-08       Impact factor: 4.530

3.  L-deprenyl plus L-phenylalanine in the treatment of depression.

Authors:  W Birkmayer; P Riederer; W Linauer; J Knoll
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

4.  Dl-phenylalanine in depressed patients: an open study.

Authors:  H Beckmann; M A Strauss; E Ludolph
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

5.  DL-phenylalanine versus imipramine: a double-blind controlled study.

Authors:  H Beckmann; D Athen; M Olteanu; R Zimmer
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1979-07-04

6.  Correlations of plasma and urinary phenylacetic acid and phenylethylamine concentrations with eating behavior and mood rating scores in brofaromine-treated women with bulimia nervosa.

Authors:  B A Davis; S H Kennedy; J D'Souza; D A Durden; D S Goldbloom; A A Boulton
Journal:  J Psychiatry Neurosci       Date:  1994-07       Impact factor: 6.186

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.